Petros Pharmaceuticals Inc (NAS:PTPI)
$ 0.61 -0.0035 (-0.57%) Market Cap: 4.27 Mil Enterprise Value: 2.11 Mil PE Ratio: 0 PB Ratio: 0.43 GF Score: 44/100

Petros Pharmaceuticals Inc Benzinga Global Small Cap Conference 2021 Transcript

Oct 29, 2021 / NTS GMT
Release Date Price: $17.4 (+1.75%)
Spencer Israel
Benzinga - Analyst

Let's bring on our next. Fady Boctor, he is the Chief Commercial Officer and President of Petros Pharma. There he is. Fady, since we last spoke, you clearly have not moved. I have moved; you have not. You've been in the same seat, but good to see you again.

`Let's get the slides up on the screen, guys. And Fady, I will give you the floor, sir, and tell us about Petros.

Fady Boctor
Petros Pharmaceuticals, Inc. - Chief Commercial Officer & President

You got it, Spencer. Good to see you again as well. Good afternoon, everyone. We're going to dive into the Petros story and what I'll do is I'll ask you to tune into a concept.

This is a company that's known as a hidden gem. It's a hidden gem because it's operating in a massive marketplace that many may take for granted, and that's the men's health space. We have a flagship cornerstone revenue-generating asset in the ED space, erectile dysfunction, which we'll dive into, that has potential to disrupt the marketplace, we'll talk about how, as well as devices and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot